Skip to content

Comparison of Posterior Continuous Curvilinear Capsulorhexis With or Without Anterior Vitrectomy

Comparison of Posterior Continuous Curvilinear Capsulorhexis With or Without Anterior Vitrectomy in Congenital Cataract Surgery

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05136209
Enrollment
50
Registered
2021-11-29
Start date
2021-11-01
Completion date
2026-11-01
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Cataract

Keywords

Congenital cataract surgery, anterior vitrectomy, postoperative complications

Brief summary

Selecting the appropriate surgical approach for congenital cataracts presents challenging for ophthalmologists. This prospective, randomized controlled study aims to compare the prognosis of posterior continuous curvilinear capsulorhexis (PCCC) with or without anterior vitrectomy (A-Vit) in treating congenital cataracts.

Detailed description

Due to the particularity of children's eye structure, selecting the appropriate surgical approach for congenital cataracts presents challenging for ophthalmologists. The major concerned postoperative problem is the after-cataract formation. As a result, PCCC with A-Vit is usually performed to prevent the formation of secondary cataracts. However. Debate over the indication and surgical procedure still persists since A-Vit and excessive manipulations may interfere with the development of the eye and increase the risk of postoperative inflammation, unstable intraocular pressure, macular edema, retinal detachment and so on. Thus, it is necessary to evaluate the safety and effectiveness of PCCC without A-Vit in congenital cataract surgery. In this randomized clinical trial, children with equal degree of congenital cataract in both eyes are enrolled. Patients receive cataract surgery on both eyes on the same day. For each patient, one eye is randomly assigned to undergo PCCC+A-Vit procedure, while the fellow eye is undergoing PCCC procedure without A-Vit. PCCC+A-Vit procedure includes anterior continuous curvilinear capsulorhexis (ACCC), irrigation/aspiration (I/A), PCCC, and A-Vit. Primary intraocular lens implantation (IOL) is performed in children older than age of two. Investigators then compare the incidence of visual axis opacity, uveitis, iris/pupil abnormality and intraocular pressure between two groups.

Interventions

PROCEDUREPCCC procedure without A-vit

In this randomized clinical trial, patients receive cataract surgery on both eyes on the same day. For each patient, one eye is randomly assigned to undergo PCCC+A-Vit procedure, while the fellow eye is undergoing PCCC procedure without A-Vit.

PROCEDUREPCCC+A-Vit procedure

PCCC+A-Vit procedure

Sponsors

Sun Yat-sen University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
1 Months to 18 Years
Healthy volunteers
No

Inclusion criteria

* Children with bilateral congenital cataracts without other ocular abnormalities * Gestational age at birth \>37 weeks * No more than 18 years old * Pupils could dilate normally pre-operation * Have signed a consent form * Can be followed

Exclusion criteria

* Intraocular pressure \>21 mmHg * History of ocular trauma and intraocular surgery

Design outcomes

Primary

MeasureTime frameDescription
Number of participants with visual axis opacification5 yearsNumber of participants with visual axis opacification evaluated based on the retro-illumination.
Number of participants with uveitis and iris/pupil abnormality5 yearsNumber of participants with uveitis and iris/pupil abnormality evaluated based on the slip lamp examination.
IOP5 yearsIntraocular pressure measured by the Tono-pen or non-contact tonometer

Secondary

MeasureTime frameDescription
BCVA change5 yearsChange from baseline in the best corrected visual acuity (BCVA) measured by the Teller's acuity card, the Lea symbol visual acuity chart or the ETDRS chart according the patient's age.
CFT change5 yearsChange from baseline in the central foveal thickness (CFT) measured by Optical Coherence Tomography (OCT)
AL change5 yearsChange from baseline in axial length measured by AL-Scan, IOLMaster or A-scan
CCT change5 yearsChange from baseline in the central corneal thickness (CCT) measured by pentacam.

Countries

China

Contacts

Primary ContactTingfeng Qin
qintf3@mail2.sysu.edu.cn13724104066

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026